financetom
Business
financetom
/
Business
/
Exxon Mobil, QatarEnergy JV Golden Pass LNG Asks for Extension to Complete Construction Until 2029
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Exxon Mobil, QatarEnergy JV Golden Pass LNG Asks for Extension to Complete Construction Until 2029
Sep 1, 2024 8:45 PM

03:46 PM EDT, 08/29/2024 (MT Newswires) -- Exxon Mobil ( XOM ) and QatarEnergy joint venture Golden Pass LNG has asked the US Federal Energy Regulatory Commission for an extension to complete the $10 billion liquefied natural gas export facility in Texas until November 2029 due to a change in primary contractors, Golden Pass said in a Wednesday letter to the regulator.

Golden Pass currently has until Nov. 30, 2026, to complete the project.

Golden Pass also filed a request with the US Department of Energy's Office of Fossil Energy and Carbon Management for an extension of its export authorizations to begin commercial operations from its terminal facilities until March 31, 2027, according to the letter to the FERC.

"Our goal is to produce first LNG around the end of 2025 with commercial operations following thereafter," a spokesman for Golden Pass said in a Thursday email to MT Newswires. "Consistent with our previous regulatory extensions, the extensions we have requested build in time for contingencies to account for uncertainties outside of the company's control that can arise when constructing a project of this scale."

Exxon Mobil ( XOM ), QatarEnergy and the FERC did not immediately respond to requests for comment by MT Newswires.

Price: 118.40, Change: +1.88, Percent Change: +1.61

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-NxGen Brands, Inc. Announces the Official Acquisition of Top Handmade Fudge and Candy Company, Genesee Candy Land and Genesee Fudge Factory
BRIEF-NxGen Brands, Inc. Announces the Official Acquisition of Top Handmade Fudge and Candy Company, Genesee Candy Land and Genesee Fudge Factory
Oct 20, 2025
Oct 20 (Reuters) - Nxgen Brands Inc ( NXGB ): * NXGEN BRANDS, INC. ( NXGB ) ANNOUNCES THE OFFICIAL ACQUISITION OF TOP HANDMADE FUDGE AND CANDY COMPANY, GENESEE CANDY LAND AND GENESEE FUDGE FACTORY Source text: Further company coverage: ...
Cerrado Gold Cuts 2025 Production Guidance as Details Q3 Production and 2026 Plan For Minera Don Nicolas Mine in Argentina
Cerrado Gold Cuts 2025 Production Guidance as Details Q3 Production and 2026 Plan For Minera Don Nicolas Mine in Argentina
Oct 20, 2025
09:22 AM EDT, 10/20/2025 (MT Newswires) -- Cerrado Gold ( CRDOF ) on Monday reduced its 2025 gold equivalent production guidance at the Minera Don Nicolas mine in Argentina, while its output dropped year over year in the third quarter. The company cut its guidance to a range of 50,000-55,000 ounces from the previous target of 55,000-60,000 ounces, citing a...
Radiopharm Theranostics Says Data From Clinical Programs Expected in Near Term
Radiopharm Theranostics Says Data From Clinical Programs Expected in Near Term
Oct 20, 2025
09:20 AM EDT, 10/20/2025 (MT Newswires) -- Radiopharm Theranostics ( RADX ) said Monday it expects to provide topline data readouts from its four lead clinical programs in the near term. The company also said it plans to begin phase 1 trials for RV01 and RAD402 antibody assets by year-end. Radiopharm said data from the first two cohorts in its...
Immutep Says its Mid-Stage Trial of Eftilagimod Alfa Meets Primary Endpoint of Tumor Hyalinization/Fibrosis
Immutep Says its Mid-Stage Trial of Eftilagimod Alfa Meets Primary Endpoint of Tumor Hyalinization/Fibrosis
Oct 20, 2025
09:20 AM EDT, 10/20/2025 (MT Newswires) -- Immutep ( IMMP ) said Monday that its Eftisarc-neo mid-stage study of eftilagimod alfa with radiotherapy plus Keytruda has met its primary endpoint and significantly exceeded the trial's prespecified 35% tumor hyalinization/fibrosis. The company said the trial enrolled 38 participants and found that the novel combination with eftilagimod alfa resulted in a median...
Copyright 2023-2026 - www.financetom.com All Rights Reserved